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Structural biology research generates large amounts of data, some deposited in public databases or re-
positories, but a substantial remainder never becomes available to the scientific community. In addition,
some of the deposited data contain less or more serious errors that may bias the results of data mining.
Thorough analysis and discussion of these problems is needed to ameliorate this situation. This perspec-
tive is an attempt to propose some solutions and encourage both further discussion and action on the
part of the relevant organizations, in particular the PDB and various bodies of the International Union of
Crystallography.Introduction
During the last 3 years, a number of publications and editorials
have raised the issue of the reproducibility of scientific results
in a variety of disciplines. Although the ability to reproduce
published results is generally recognized as a defining charac-
teristic of science, in recent years the number of published
biomedical research findings that cannot be repeated outside
of the original laboratory has been rising at an alarming rate.
For example, some pharmaceutical companies have revealed
that they can independently verify fewer than 25% of preclini-
cal cancer studies published in major journals (Begley and
Ellis, 2012). Other sobering reports indicate that up to 75%
of experiments performed on drug targets in a given laboratory
cannot be repeated elsewhere (Prinz et al., 2011). It is tempting
to assume that the problem is limited to academic researchers
cutting corners because of grant applications, tenure deci-
sions, and other forms of ‘‘publish or perish’’ pressure, but
some papers published by industrial researchers describe
results that cannot be replicated elsewhere as well (Choi
et al., 2008; Gillmor et al., 1997). The price tag of the
irreproducibility of published results was recently estimated
to be in the vicinity of 28 billion dollars per annum (Freedman
et al., 2015), almost equivalent to the entire annual budget of
the NIH.
The NIH (Collins and Tabak, 2014) and leading journals
(McNutt, 2014) have been working on guidelines to improve
the reproducibility of published research. The peer-review pro-
cess sometimes requires the availability of the experimental
data. For example, recognizing ‘‘bad’’ macromolecular crystal
structures is surely an important part of peer review of the sub-
mission of a structural biology research article. Since most of
the biostructural research rests upon the atomic coordinates
derived from X-ray diffraction data, peer review cannot divorce
the experimental data from thewords that are written. The chem-
ical crystallography community recognized this many years ago216 Structure 24, February 2, 2016 ª2016 Elsevier Ltd All rights reseand, largely via the International Union of Crystallography (IUCr)
Journals Commission, reached a consensus in the early 1990s
on community-agreed standards for crystal structure articles
and data. It was also agreed that all article submissions have
to be accompanied by atomic coordinates and structure factor
amplitudes. To make matters as manageable as possible, a
checkcif report (Spek, 2009) was made available to submitting
authors, referees, and the co-editor. The report presented alerts
of various levels of seriousness, indicated via an A, B, C system
of tags that needed to be considered by the authors. ‘‘A’’ alerts
were essential to be dealt with or responded to. This then
became an exemplary approach, agreed to by the chemical
crystallography community and driven forward by IUCr journals
(namely Acta Crystallographica Section C). J.R.H., at that time
the Editor-in-Chief of IUCr Journals, proposed at the IUCr
Congress in Geneva the adoption of a similar system by the
macromolecular crystallography community. Unfortunately, the
proposal was rejected on two grounds. It was stated, first, that
confidentiality of the peer review of a biological crystal structure
article submission’s data could not be guaranteed and thus
conflicts with competition would be possible, and second, that
the commercial potential of a given research result could be
compromised.
The relatively recent adoption by most journals of a policy
requiring the submission of a PDB validation report (Read
et al., 2011) as an obligatory companion of a biological crystal-
lography article submission represents a step forward. Whereas
the validation report might be a guide to the authors, referees,
editor, and finally the readers and users, it is an inadequate sub-
stitute for the coordinates and diffraction data themselves made
available at the time of submission of a structural article.
Need for Community-Agreed Standards
What are the crucial parameters that could be used to assess
the correctness of macromolecular structures and help therved
Figure 1. The Cumulative Number of Structures in the PDB with a
Primary Citation ‘‘to be Published’’
Only structures that have beenmarked ‘‘to be published’’ for more than 2 years
since deposition are taken into consideration. Structures deposited by
structural genomics (SG) consortia (red) represent roughly 50% of the ‘‘to be
published’’ category.
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key parameter that has been consistently difficult to define is
the resolution limit of useful diffraction data. Over time a variety
of criteria have been proposed, and subsequently abandoned,
by the protein crystallography community. Examples include
the resolution limit where Rmerge is lower than 20%, or where
<I/s(I)> is less than 2.0, or, most recently, where CC1/2 becomes
less than 0.5. Other situations in which the liberty of ‘‘interpreta-
tion’’ caused hiatus at different times in the field include unre-
stricted addition of buckets of water molecules or (over)interpre-
tation of ever-diminishing electron density features (not even on
an absolute scale), and the challenge of electron density blobs,
for which a mix of community approaches of attempted inter-
pretation or ignoring them altogether ebb and flow. Definitive
standards on these and other points need urgent debate and
consistent enforcement of the guidelines by scientific journals,
and certainly at least by IUCr journals.
Journal Publications versus Deposits to Repositories/
Databases
However, results (questionable or not) published in peer-review
journals are only a fraction of the data that are never published
but are deposited at increasing rates in various biomedical re-
positories and databases (Figure 1 shows an example taken
from the PDB). The presence of inaccurate, incomplete, and/
or self-contradictory information in these databases may have
a disastrous effect on data mining (Dauter et al., 2014; Zheng
et al., 2008). In addition, the underestimated ‘‘ripple effect’’ of
dissemination of questionable results may lead to ‘‘creeping
entropy,’’ i.e. to accumulation of inconsistent or plainly wrong
data, undermining users’ confidence in the usefulness of scien-
tific results. This problem is not unique to biology, but the far-
reaching consequences of inaccurate or inconsistent data inStructubiomedical research could be particularly painful and devas-
tating.
Data Repositories
Our experience with experimental data repositories for the
biomedical sciences shows that the data are often incomplete,
inconsistent, or even self-contradictory. Inconsistent and inac-
curate data are not limited to science but are a general plague
pervading modern life. For example, inaccurate and inconsis-
tent information may be seen at many airports, in the case
when two different monitors show two different departure times
for the same airplane. In the end, the true departure time is veri-
fied by the actual departure of the plane. At this point the
misleading information affects only the people who missed the
plane and does not have any further consequences, except
that human beings associate the error with a computer and as-
sume that such errors are just an unavoidable part of modern
life. This modern disease has propagated into science, leading
some scientists to blame software for erroneous results (Chang,
2007) and to accept, as inevitable, the inaccuracies in the
experimental procedures that may subsequently affect publica-
tions and databases.
The reporting of negative results could significantly improve
the detection of ‘‘bad apples.’’ However, the reporting of nega-
tive results in structural biology databases is also far from
satisfactory. For example, the PSI Structural Biology Knowl-
edgebase (http://sbkb.org/) provides a database collecting
experimental data for all protein targets studied by all consortia
in the Protein Structure Initiative: Biology (PSI:Biology) (Gabanyi
et al., 2011) and several other large-scale structure determina-
tion initiatives. An analysis of this database shows that fewer
than 15% of all targets contain any information about unsuc-
cessful trials.
Protein crystallography, as a major foundation of our molecu-
lar understanding of life, is generally regarded as a source of
unquestionable information. After all, we ‘‘see atoms,’’ as Sir
Lawrence Bragg so vividly described it, and the results provided
by protein crystallographers have thus established the gold stan-
dard for structural information in modern biology. For example,
many consumers of the structural information collated in the
PDB (Berman et al., 2000) treat crystal structures as ‘‘set in
stone.’’ Because of this confidence, good practices and stan-
dards for themaintenance of the unscathed integrity of structural
repositories and databases have to be preserved and continu-
ously improved.
Recently, a number of problems with structures of proteins,
their ligands, nucleic acids, carbohydrates, bound metals, and
so forth have been identified and discussed in several publica-
tions. One of the authors of this paper (J.R.H.) received a valu-
able critique of a group of crystal structures from his co-authors
(Shabalin et al., 2015), to which a response was provided
(Tanley et al., 2015). This back-and-forth process is leading to
improvements in the associated PDB files, and showcases the
advantages of the availability of all the data (including raw
diffraction images, processed structure factor amplitudes,
and the final derived coordinates) underpinning the publica-
tions (Tanley et al., 2012) and the raw data (http://dx.doi.org/
10.15127/1.215887, https://www.escholar.manchester.ac.uk/
uk-ac-man-scw:215887). More widely, the fraction ofre 24, February 2, 2016 ª2016 Elsevier Ltd All rights reserved 217
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that are most important for drug discovery studies, is not
decreasing with time. This is most probably a consequence
partly of the flood of new structures determined each year, and
partly of the availability of various sophisticated software
tools that allow relatively untrained persons to determine a
macromolecular crystal structure in a partially or fully automated
manner.
The PDB has adopted several policies that have made it one
of the most comprehensive and widely used repositories in the
biomedical sciences. The most important of these policies is
the requirement to deposit experimental structure factors,
which allow for independent re-evaluation or even re-refine-
ment of structures if problems are detected and/or deeper an-
alyses are warranted. The PDB has also adopted extensive
tools for structure validation and error detection during the
deposition process which, by their own admission, are still un-
der active development. However, even the best policies will
not improve papers that have already been published and re-
sults that have already been deposited. Prompt redress of da-
tabanks such as the PDB is essential, since even a single
incorrect structure may greatly hinder data mining research.
One prominent example is the case of PDB: 3FJ0 deposit,
which contained hundreds of ordered water oxygen atoms
mislabeled as Na+ ions. This structure almost singlehandedly
biased all analyses of bond geometries in the PDB involving
Na+ ions (Chruszcz et al., 2010). Deposit PDB: 3FJ0 was finally
corrected 4 years after its original deposition and 2 years
after the problem had been identified. In the meantime, the
incorrect structure was downloaded several thousand
times and potentially polluted many subsequent analyses
and databases.
Policies Regarding Corrections of Existing Deposits
Although, in principle, the conversion of the PDB from a static
repository toward a dynamic one (Dauter et al., 2014; Terwilliger
and Bricogne, 2014) with continually revised deposits should be
possible, in current practice this would require the involvement
of the original depositors and is time consuming. However, such
an approach would not be as time consuming as the original
work, which may have involved a multidisciplinary team that is
likely to have dispersed. The deposited data in all their forms
are therefore incredibly valuable. Recognizing bad apples is
not always easy. One person’s bad apple is also perhaps an-
other’s triumph over a poorly diffracting crystal or effort to
combine many biophysical techniques to interpret a difficult
portion of a structure. Nevertheless, community agreement is
needed that consistent macromolecular crystal structure stan-
dards are necessary and possible. Accompanying an article
submission with actual coordinates, structure factors, and,
ideally, raw diffraction images would properly re-ignite the dis-
cussion and quest for a much improved peer review. This point
was already raised at the IUCr Congress in Geneva, but the
question was not resolved. We believe it to be essential that
database integrity trump any individual concerns regarding in-
tellectual property or competitive disadvantage during peer re-
view. If the work is to be published it is therefore going to be in
the public record, and the community has a right to evaluate its
quality from the primary data. Supporting the dynamic and up-218 Structure 24, February 2, 2016 ª2016 Elsevier Ltd All rights resedatable database should be high on the agenda of all bio-
medically oriented research.
There are, naturally, various possible forms of the evolution of
the PDB and other databases into a dynamic resource with the
capability to systematically improve molecular models. This is
based on the very sound idea, indeed a fundamental principle,
that the originally measured data are eternal but any interpreta-
tion is subject to evolution (Chruszcz et al., 2010; McNutt,
2015). For example, any new crystallographic model would be
made available together with all precursor models, even though
the authors of the original data and atomicmodel may ormay not
agree with the new re-interpretations of their data (Shabalin
et al., 2015). Regardless of the circumstances, the exact contri-
butions of each interpreter of Nature’s Truth should be made
very clear to the users of this repository. The dynamic form of
the repository would indirectly enforce the requirement that
experimental data include all measurements that are needed to
reproduce the reported results; for example, anomalous scat-
tering data, when utilized in structure determination, should be
formally required. The ideal solution would be to link each PDB
deposit to the experimental data that could be used for de
novo structure determination, for example when the interpreta-
tion of ligands, or indeed any structural feature, is contested.
There are also new opportunities to be expected when the usual
Bragg diffraction intensities are supplemented by the diffuse
scattering outside the Bragg spots. This promising new method
of analysis, as well as other currently unforeseen types of ana-
lyses, will only be possible when the raw diffraction images are
in open archives. Thus ‘‘full diffraction pattern’’ analyses based
on an ensemble of molecules, e.g. as initially derived from
molecular dynamics simulations, could become much more
frequent. For a recent example of such work, see Wall et al.
(2014).
We note, and welcome, the new initiatives to create pilot
resources for archiving the original experimental data. Exam-
ples of such efforts are the NIH Big Data to Knowledge
(BD2K) initiative and a number of other resources, such
as http://www.proteindiffraction.org/ (USA), http://zenodo.org
(Europe), https://store.synchrotron.org.au/public_data/ (Meyer
et al., 2014) (Australia), and Structural Biology Data Grid
(https://data.sbgrid.org/) (USA). Two pioneering resources, the
Joint Center for Structural Genomics (JCSG) depository and
Joint Center for Structural Genomics of Infectious Diseases
and Seattle Structural Genomics Center for Infectious Diseases
resource, are now part of the BD2K initiative. The BD2K initiative
is by far the largest, and currently comprises almost 2,900 in-
dexable and searchable diffraction experiments. The raw
diffraction images may be useful for instructional purposes
and as training sets for methods developers, as well as the chal-
lenges of recalcitrant, difficult structures. All these resources
sustain a policy of generating a permanent digital object identi-
fier (doi) as part of the process. Extensive detailed discussion
can be found in the set of articles in the October 2014 issue
of Acta Crystallographica D. The IUCr journals Journal of
Applied Crystallography and Acta Crystallographica D and F
have recently started linking their publications with primary
datasets.
We note here that the need for and the practical problems con-
nected with archiving of the primary experimental images is notrved
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tion cryoelectron microscopy methodology (Doerr, 2015; Egel-
man, 2016) also produces voluminous amounts of digitally
stored raw image information (https://www.ebi.ac.uk/pdbe/
emdb/empiar). It can be hoped that the solutions worked out
in one of these disciplines will stimulate in a mutual way similar
advancements in the other.
Conclusions and Recommendations
Having defined the problems, we would like to propose as
solutions:
d The community at large is encouraged to instigate
repeated validations of archived structural and other
biomedical data and to promote corrective actions when
needed. Overall, this ‘‘crowd sourcing’’ approach will
further strengthen the correctness and thereby the useful-
ness of structural databases, prevent any diminishing trust
in the deposited data, and ameliorate the serious effects of
irreproducibility. Such actions should be spearheaded by
the data centers themselves (most notably the PDB) so
that it is a coordinated process, but also by leading interna-
tional organizations (e.g. IUCr), funding agencies (e.g. NIH),
and the leading journals (e.g. Nature, Science, Structure,
Protein Science, etc.).
d Deposition of experimental raw data by research groups
should become a standard and should be performed via
established repositories capable of assigning DOIs (Guss
andMcMahon, 2014). These repositories may either be es-
tablished as part of the PDB itself or via the journal initia-
tives described above. We note that links between the
PDB and some of the experimental raw data repositories
are currently being established.
d The journals publishing biological structures should start
to formally require that diffraction data (or chemical shifts
in the case of nuclear magnetic resonance) and atomic
coordinates should be made available to the reviewers
and editors at the time of article submission. These
data may be accessible via the PDB through a
secure, password-protected channel with all accesses
recorded to ensure the maximal safety of the potentially
restricted data. The PDB submission should contain not
only the diffraction data used for refinement, but also
the data (e.g. anomalous data) used for structure
determination.
d If appropriate, the journals publishing methodological
advancements should require deposition of experimental
datasets that were used to illustrate the advantage of
new methodology.
Whereas it is true that the PDB is rightly seen as an open-
access exemplar, the importance of primary data archiving is
increasingly recognized as described above. As a minimum
course of action, we therefore recommend that the IUCr Com-
mission on Biological Macromolecules discusses our proposals
at the upcoming international crystallographic conferences in
different regions of the world, with a view to their formal adop-
tion at the next IUCr Congress in Hyderabad, India, in August
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